|
|
| | Norbolethone Basic information |
| Product Name: | Norbolethone | | Synonyms: | (.+-.)-13-Ethyl-17-hydroxy-18,19-dinor-17.alpha.-pregn-4-en-3-one;18,19-Dinor-17.alpha.-pregn-4-en-3-one, 13-ethyl-17-hydroxy-;18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-;Aids125925;Aids-125925;Gon-4-en-3-one, 13.beta.,17.alpha.-diethyl-17-hydroxy-;Norbalethone;α-Norbolethone | | CAS: | 797-58-0 | | MF: | C21H32O2 | | MW: | 316.482 | | EINECS: | | | Product Categories: | | | Mol File: | 797-58-0.mol |  |
| | Norbolethone Chemical Properties |
| Boiling point | 395.89°C (rough estimate) | | density | 1.0382 (rough estimate) | | refractive index | 1.5344 (estimate) | | pka | 15.13±0.40(Predicted) | | color | Anabolic steroid |
| Toxicity | LD50 orl-mus: 5010 mg/kg TXAPA9 18,185,71 | | DEA Controlled Substances | CSCN: 4000
CSA SCH: Schedule III
NARC: No |
| | Norbolethone Usage And Synthesis |
| Uses | Anabolic. | | Safety Profile | Mildly toxic by ingestion.Experimental reproductive effects. When heated todecomposition it emits acrid smoke and irritating fumes. |
| | Norbolethone Preparation Products And Raw materials |
|